# Donepezil for Oxaliplatin-induced Neuropathy Peripheral Neuropathy: Proof of Concept Study

> **NCT05254639** · PHASE2 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 77 (actual)

## Conditions studied

- Digestive Oncology
- Supportive Care

## Interventions

- **DRUG:** DONEPEZIL
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT05254639
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-02
- **Primary completion:** 2024-01-24
- **Final completion:** 2024-01-24
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2024-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254639, "Donepezil for Oxaliplatin-induced Neuropathy Peripheral Neuropathy: Proof of Concept Study". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT05254639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*